Recent Advances, Approaches and Challenges in the Development of Universal Influenza Vaccines
Influenza and Other Respiratory Viruses · 2024-03 · 18 (3)
DOI: 10.1111/irv.13276 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Influenza and Other Respiratory Viruses, online erschienen am 21.03.2024. Verfasst von Caryn Myn Li Lim und 4 weiteren Autor:innen. Beteiligte Einrichtung: Infection and Immunity Research Strength, Jeffrey Cheah School of Medicine & Health Sciences, Monash University Malaysia, Bandar Sunway, Malaysia. Hauptthemen laut MEDLINE: Influenza Vaccines, Influenza, Human, Orthomyxoviridae, Orthomyxoviridae Infections. Die Arbeit wurde bisher 53-mal zitiert (Crossref) und nennt 123 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Every year, influenza virus infections cause significant morbidity and mortality worldwide. They pose a substantial burden of disease, in terms of not only health but also the economy. Owing to the ability of influenza viruses to continuously evolve, annual seasonal influenza vaccines are necessary as a prophylaxis. However, current influenza vaccines against seasonal strains have limited effectiveness and require yearly reformulation due to the virus undergoing antigenic drift or shift. Vaccine mismatches are common, conferring suboptimal protection against seasonal outbreaks, and the threat of the next pandemic continues to loom. Therefore, there is a great need to develop a universal influenza vaccine (UIV) capable of providing broad and durable protection against all influenza virus strains. In the quest to develop a UIV that would obviate the need for annual vaccination and formulation, a multitude of strategies is currently underway. Promising approaches include targeting the highly conserved epitopes of haemagglutinin (HA), neuraminidase (NA), M2 extracellular domain (M2e) and internal proteins of the influenza virus. The identification and characterization of broadly neutralizing antibodies (bnAbs) targeting conserved regions of the viral HA protein, in particular, have provided important insight into novel vaccine designs and platforms. This review discusses universal vaccine approaches presently under development, with an emphasis on those targeting the highly conserved stalk of the HA protein, recent technological advancements used and the future prospects of a UIV in terms of its advantages, developmental obstacles and potential shortcomings.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Infection and Immunity Research Strength, Jeffrey Cheah School of Medicine & Health Sciences, Monash University Malaysia, Bandar Sunway, Malaysia.
ORCID-Profile: Nur Amelia Azreen Binti Adnan
Zitieren
APA
Lim, C. M. L., Komarasamy, T. V., Adnan, N. A. A. B., Radhakrishnan, A. K., & Balasubramaniam, V. R. M. T. (2024). Recent Advances, Approaches and Challenges in the Development of Universal Influenza Vaccines. Influenza and Other Respiratory Viruses, 18(3). https://doi.org/10.1111/irv.13276
Vancouver
Lim CML, Komarasamy TV, Adnan NAAB, Radhakrishnan AK, Balasubramaniam VRMT. Recent Advances, Approaches and Challenges in the Development of Universal Influenza Vaccines. Influenza and Other Respiratory Viruses. 2024;18(3). doi:10.1111/irv.13276
BibTeX
@article{Lim2024,
author = {Lim, Caryn Myn Li and Komarasamy, Thamil Vaani and Adnan, Nur Amelia Azreen Binti and Radhakrishnan, Ammu Kutty and Balasubramaniam, Vinod R M T},
title = {Recent Advances, Approaches and Challenges in the Development of Universal Influenza Vaccines},
journal = {Influenza and Other Respiratory Viruses},
year = {2024},
volume = {18},
number = {3},
doi = {10.1111/irv.13276}
}
EUVIMED